Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Why use cells in regenerative medicine?
- Regenerative medicine/tissue engineering
- Why use cells at all?
- Cell issues - intellectual property
- Human ES cells - the choice?
- Ethics (1)
- Ethics (2)
- Cell issues- source of cells
- Bone marrow transplant
- Cord blood
- Stem cell technology problems
- Smart bioreactors
- Chondrogenic differentiation from ES cells
- TheraMachine - working prototype
- Bioprocessing system
- HARV - micro-CT
- Differentiation of stem cells
- hESC encapsulation
- Lung epithelium differentiation
- Strategy (1)
- Best cell to commercialize
- Stem cell products
- Lung disease in the EEC and UK
- Lung disease in the USA
- Vision: lung
- Strategy (2)
- Novalung - interventional lung assist
- Lung assist device
- Cannulation of A./V. femoralis
- BioHybrid toxicology
- Human therapeutics
- Managing expectations
- We have been here before
- Investors
- Commercial stem cell technology
- Commercial cell products
- The best cells for commercial applications
- The best stem cells for commercial applications
- End of presentation
Topics Covered
- Why use stem cells?
- The IP problems of commercializing stem cell research
- Ethics and commercialization
- Selecting stem cells for commercial development
- Producing cells for product development
- Scale-up and quality issues
- The promise of automation
- Developing a product
- Lung disease: the medical need and the approach
- Simplifying the strategy by simplifying the product
- R&D of a lung assist device for lung therapeutics
- The key lesson for commercial development
Talk Citation
Roberts, G. (2007, October 1). Commercialisation of stem cells [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 7, 2024, from https://doi.org/10.69645/WQNB6419.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Gareth Roberts has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.